Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

    Macle, L; Cairns, J; Leblanc, K; Tsang, T; Skanes, A; Cox, JL; Healey, JS; Bell, A; Pilote, L; Andrade, JG; Mitchell, LB; Atzema, C; Gladstone, D; Sharma, M; Verma, S; Connolly, S; Dorian, P; Parkash, R; Talajic, M; Nattel, S; Verma, A.
    Can J Cardiol; 32 (10), 2016
    The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF pa...
    Anticoagulantes, Cardiotónicos, Inhibidores de Agregación Plaquetaria, Digoxina, Magnesio, Síndrome Coronario Agudo/terapia, Algoritmos, Anticoagulantes/uso terapéutico, Apéndice Atrial/cirugía, Fibrilación Atrial, Estimulación Cardíaca Artificial, Cardiotónicos/efectos adversos, Ablación por Catéter, Cardiotónicos/administración & dosificación, Fibrilación Atrial/terapia, Fibrilación Atrial/complicaciones, Hemorragia/inducido químicamente, Hemorragia/prevención & control, Magnesio/uso terapéutico, Intervención Coronaria Percutánea, Inhibidores de Agregación Plaquetaria/uso terapéutico, Complicaciones Posoperatorias/prevención & control, Infarto del Miocardio con Elevación del ST/terapia, Accidente Cerebrovascular/prevención & control, Enfermedad de la Arteria Coronaria/complicaciones, Digoxina/administración & dosificación, Digoxina/efectos adversos, Quimioterapia Combinada, Inhibidores del Factor Xa/uso terapéutico, Fibrinolíticos/uso terapéutico, Inhibidores del Factor Xa
    Texto completo

    Evidence and consensus-based (S3) guidelines for the treatment of actinic keratosis: International League of Dermatological Societies in cooperation with the European Dermatology Forum: short version

    Werner, R. N; Stockfleth, E; Connolly, S. M; Correia, O; Erdmann, R; Foley, P; Gupta, A. K; Jacobs, A; Kerl, H; Lim, H. W; Martin, G; Paquet, M; Pariser, D. M; Rosumeck, S; Röwert-Huber, H. J; Sahota, A; Sangueza, O. P; Shumack, S; Sporbeck, B; Swanson, N. A; Torezan, L; Nast, A.
    J. Eur. Acad. Dermatol. Venereol; 29 (11), 2015
    BACKGROUND: Actinic keratosis (AK) is a frequent health condition attributable to chronic exposure to ultraviolet radiation. Several treatment options are available and evidence based guidelines are missing. OBJECTIVES: The goal of these evidence- and consensus-based guidelines was the development of tre...
    Queratosis Actínica/terapia, Rayos Ultravioleta/efectos adversos, Terapia Combinada
    Texto completo